Citations

Citations to this article as recorded by  

• A patient-reported outcome measure comprising the stool frequency and abdominal pain items from the Crohn’s Disease Activity Index: psychometric evaluation in adults with Crohn’s disease
  James D. Lewis, Aisha Vadhariya, Sylvia Su, Xian Zhou, Frederick Durand, Ariane K. Kawata, Larissa Stassek, Claudine Clucas, Stefan Schreiber
  Journal of Patient-Reported Outcomes.2025;[Epub]     CrossRef
• Depression and active disease are the major risk factors for fatigue and sleep disturbance in inflammatory bowel disease with consequent poor quality of life: Analysis of the interplay between psychosocial factors from the developing world
  Partha Pal, Rupa Banerjee, Polina Vijayalaxmi, D. Nageshwar Reddy, Manu Tandan
  Indian Journal of Gastroenterology.2024; 43(1): 226.     CrossRef
• Research Progress in the Study of Biomarkers for Diagnosing Ulcerative Colitis or Assessing Its Activity
  琳 杨
  Advances in Clinical Medicine.2024; 14(01): 1167.     CrossRef
• A novel serum biomarker of endoscopic mucosal healing in inflammatory bowel disease
  Hyoun Woo Kang
  Intestinal Research.2024; 22(1): 3.     CrossRef
• The prevalence and burden of Rome IV faecal incontinence in ulcerative colitis: A cross‐sectional study
  Dipesh H. Vasant, Gaurav B. Nigam, Sebastian Bate, Shaheen Hamdy, Jimmy K. Limdi
  Alimentary Pharmacology & Therapeutics.2023; 58(1): 26.     CrossRef
• Current and emerging biomarkers for ulcerative colitis
  Jan K. Nowak, Rahul Kalla, Jack Satsangi
  Expert Review of Molecular Diagnostics.2023; 23(12): 1107.     CrossRef